The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 301–400 of 772
Gilmore, D., Longo, A., & Hand, B. N. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05275-3 · Cited by 20
Is low cholesterol a risk factor for cancer mortality?
Parsa, N., Taravatmanesh, S., & Trevisan, M. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000391 · Cited by 18
“Introduction A number of studies (Agner and Hansen, 1983; Wingard et al., 1984; Reed et al., 1986; Trialists, 2010; Cui et al., 2012; Tanaka and Okamura, 2012; Bombelli et al., 2013; LaRosa et al., 2013; Liu et al., 2013; Sahebzamani et al., 2013; Singh et al., 2013; Whelton et al., 2013; Nishikura et al., 2014; Tamos…”
BackgroundA review of the neurobiology of obesity and the available pharmacotherapies
Subramaniapillai, M., & McIntyre, R. S. (2017) · CNS Spectrums · doi:10.1017/s1092852917000839 · Cited by 19
Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk
Naude, C. E., Schoonees, A., Nguyen, K. A., Senekal, M., Young, T., Garner, P., Chaplin, M., & Volmink, J. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013334 · Cited by 18
Does prolonged television viewing affect Body Mass Index? A case of the Kingdom of Saudi Arabia
Al‐Hanawi, M. K., Chirwa, G. C., Pemba, L. A., & Qattan, A. M. N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228321 · Cited by 19
Adeyemi, W. J., Olayaki, L. A., Abdussalam, T. A., Ige, S. F., Okesina, K. B., Abolarin, P. O., Usman, H., Tiamiyu, A. O., Seidu, M. O., & Opabode, A. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100192 · Cited by 19
Single‐cell RNA sequencing of preadipocytes reveals the cell fate heterogeneity induced by melatonin
Li, Z., Zheng, M., Mo, J., Li, K., Yang, X. X., Guo, L., Zhang, X., Abdalla, B. A., & Nie, Q. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12725 · Cited by 20
Wagner, J., Zanker, N., Duprée, A., Mann, O., Izbicki, J. R., & Wolter, S. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-06252-8 · Cited by 22
“Obesity increases the risk of chronic diseases, including cardiovascular disease, diabetes mellitus, kidney diseases [3], musculoskeletal diseases [4] and cancer [5].”
BackgroundAssociation between preventable risk factors and metabolic syndrome
Shehri, H. A. A., Asmari, A. K. A., Khan, H. A., Al-Omani, S. F., Kadasah, S., Horaib, G. B., Buraidi, A. A. A., Al-Sharif, A. A., Mohammed, F. S., Abbasmanthiri, R., et al. (2022) · Open Medicine · doi:10.1515/med-2021-0397 · Cited by 19
“It has been shown that alarming rates of some risk factors increase with age in cases of diabetes, hypertension, and obesity, and they could be attributed to uncontrolled hyperglycemia and reduced PA in older individuals [8,20].”
BackgroundStatins in the elderly: an answered question?
Zoungas, S., Curtis, A. J., Tonkin, A. M., & McNeil, J. J. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000082 · Cited by 19
Wang, J., Masters, W. A., Bai, Y., Mozaffarian, D., Naumova, E. N., & Singh, G. M. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2019-002120 · Cited by 16
Self-citationKwon, J., Choi, J., Lee, S.-W., Kim, M.-K., Park, Y. K., Park, D. H., & Kim, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-74110-z · Cited by 18
Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity
Petri, K. C. C., Hale, P. M., Hesse, D., Rathor, N., & Mastrandrea, L. D. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12799 · Cited by 22
McKenzie, B. L., Pinho‐Gomes, A., & Woodward, M. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124000120 · Cited by 20
Self-citationCho, C., & Lee, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179274 · Cited by 18
Obesity and type 2 diabetes mellitus: insights from skeletal muscle extracellular matrix remodeling
Wu, L., & Coletta, D. K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2024 · Cited by 18
Lipidomic Phenotyping Reveals Extensive Lipid Remodeling during Adipogenesis in Human Adipocytes
Miehle, F., Möller, G., Cecil, A., Lintelmann, J., Wabitsch, M., Tokarz, J., Adamski, J., & Haid, M. (2020) · Metabolites · doi:10.3390/metabo10060217 · Cited by 21
“a range of physiological processes, thereby increasing the risk of developing diseases like type 2 diabetes [2], cardiovascular diseases [2,3], and some types of cancer [4].”
BackgroundTesfaye, A., Josef, H., Wube, T. B., Girma, Z., Negasa, B., Muche, T., & Zewude, B. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s254883 · Cited by 19
Al-Najim, W., Raposo, A., BinMowyna, M. N., & le Roux, C. W. (2025) · Nutrients · doi:10.3390/nu17111934 · Cited by 16
Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways
Paquette, M., Yan, M., Ramírez-Reyes, J. M. J., El–Houjeiri, L., Biondini, M., Dufour, C. R., Jeong, H., Pacis, A., Giguère, V., Estall, J. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99958-7 · Cited by 17
Grave, C., Bonaldi, C., Carcaillon‐Bentata, L., Gabet, A., Halimi, J., Tzourio, C., Béjot, Y., Torres, M. J., Steg, P. G., Durand‐Zaleski, I., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23760 · Cited by 17
“28,53 RR varied according to 5-year age groups 52 (Table S1), and for CVD and CKD, we combined the RRs for each specific age with the SBP level for the same age category.”
Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity
Garrison, C. B., Lastwika, K. J., Zhang, Y., Li, C. I., & Lampe, P. D. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00611 · Cited by 18
Exposure to Vinyl Chloride and Its Influence on Western Diet-Induced Cardiac Remodeling
Liang, Y., Lang, A. L., Zhang, J., Chen, J., Wang, K., Chen, L., Beier, J. I., Qian, Y., & Cai, L. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00043 · Cited by 16
Patterson, K. A. E., Ferrar, K., Gall, S., Venn, A., Blizzard, L., Dwyer, T., & Cleland, V. J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105861 · Cited by 19
Yan, B., Liu, D., Zhang, C., Zhang, T., Wang, X., Yang, R., Liu, Y., He, D., & Zhou, Y. (2018) · Europe PMC (PubMed Central) · Cited by 18
Bombesin Receptor Subtype-3 in Human Diseases
Li, M., Peng, L., Liu, D., Yuan, F., Chen, G.-C., Zhang, L., Liu, Y., & Liu, H. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.11.004 · Cited by 16
Li, J., Qiu, Z., Liu, Z., Zhou, Q., Feng, L.-F., Li, J., & Zhang, X. (2020) · Obesity Facts · doi:10.1159/000512294 · Cited by 20
Cross-sectional association of meal skipping with lipid profiles and blood glucose in Chinese adults
Chen, L., Li, X., Du, X., Liu, W., Du, J. K., Guo, L., Xia, S., Yuan, Y., Zheng, Y., Wu, S., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111245 · Cited by 19
Huang, Y., Theis, D. R. Z., Burgoine, T., & Adams, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054804 · Cited by 21
Anti-Obesity Effects of Tocotrienols and Bran in High-Fat Diet-Treated Mice
Fukui, K., Shirai, M., Ninuma, T., & Kato, Y. (2019) · Nutrients · doi:10.3390/nu11040830 · Cited by 17
“The most important issue related to obesity is its contribution to the onset of serious diseases such as cardiovascular disease [3], type 2 diabetes mellitus [4], and hypertension [5].”
BackgroundCancers attributable to overweight and obesity in Italy
Maso, M. D., Pelucchi, C., Collatuzzo, G., Alicandro, G., Malvezzi, M., Parazzini, F., Negri, E., Boffetta, P., Vecchia, C. L., & Turati, F. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102468 · Cited by 18
Malta, D. C., Gomes, C. S., Felisbino-Mendes, M. S., Veloso, G. A., Machado, Í. E., Cardoso, L. D. O., Teixeira, R. A., Jaime, P. C., de Vasconcelos, L. L. C., Naghavi, M., et al. (2024) · Public Health · doi:10.1016/j.puhe.2023.12.037 · Cited by 21
Fritz, J., Edlinger, M., Kelleher, C., Strohmaier, S., Nagel, G., Concin, H., Ruttmann, E., Hochleitner, M., & Ulmer, H. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.048 · Cited by 19
Unsafe sexual behaviour associated with hazardous alcohol use among street-involved youth
Fairbairn, N. S., Wood, E., Dong, H., Kerr, T. H., & DeBeck, K. (2016) · AIDS Care · doi:10.1080/09540121.2016.1220480 · Cited by 17
“Health consequences secondary to chronic hazardous alcohol use include liver cirrhosis, cardiovascular disease, and cancers (Baan et al., 2007; Rehm et al., 2010; Singh et al., 2013).”
BackgroundCliment, E., Pérez‐Calahorra, S., Benaiges, D., Pintó, X., Tembra, M. S., Plana, N., Sánchez-Hernández, R. M., Valdivielso, P., Ascaso, J. F., & Pedro‐Botet, J. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.08.005 · Cited by 16
Bhoite, R., Anitha, C., Pratti, V. L., Satyavrat, V., Acharya, S., Mane, A., Mehta, S. C., Kale, R. M., Gayathri, N., Selvaraj, S., et al. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/6634225 · Cited by 15
“&e risk of CVD increases with rising fasting plasma glucose levels [3] and is the major cause of death and disability among people with diabetes [4].”
MicroRNA-126b-5p Exacerbates Development of Adipose Tissue and Diet-Induced Obesity
Shen, L., He, J., Zhao, Y., Niu, L., Chen, L., Tang, G., Jiang, Y., Hao, X., Bai, L., Li, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910261 · Cited by 15
Wavelength-Dependent Effects of Photobiomodulation for Wound Care in Diabetic Wounds
Dungel, P., Sutalo, S., Slezak, C., Keibl, C., Schädl, B., Schnidar, H., Metzger, M., Meixner, B., Hartmann, J., Oesterreicher, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065895 · Cited by 15
“4 million people die from the consequences of elevated blood sugar levels [1,2].”
BackgroundXu, T., Liu, J., Zhu, G., & Han, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051497 · Cited by 20
“Obesity is a risk factor for an expanding set of chronic diseases, including cardiovascular disease [9,10], diabetes mellitus, chronic kidney disease [9], many cancers [11], and musculoskeletal disorders [12,13].”
BackgroundFactors Affecting Metabolic Outcomes Post Bariatric Surgery: Role of Adipose Tissue
Keshavjee, S., Schwenger, K. J. P., Yadav, J., Jackson, T. D., Okrainec, A., & Allard, J. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040714 · Cited by 17
“Along with obesity comes the burden of comorbidities, such as cardiovascular disease [3], diabetes [3], nonalcoholic fatty liver disease (NAFLD) [4], and hypertension (HTN) [5].”
Screening for mild cognitive impairment in people with obesity: a systematic review
Karunathilaka, N., & Rathnayake, S. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00898-0 · Cited by 16
“Regardless of age, gender, geography or socioeconomic status, there is an increasing trend of obesity [3, 4].”
BackgroundTian, Y., Zhao, Z., Cao, X., Kang, Y., Wang, L., Yin, P., Song, Y., Zhang, L., Wang, X., Chen, Z., et al. (2023) · Med · doi:10.1016/j.medj.2023.05.008 · Cited by 14
Pauzé, E., Remedios, L., & Kent, M. P. (2021) · Public Health Nutrition · doi:10.1017/s1368980021001373 · Cited by 14
Li, A., Zhou, Q., Mei, Y., Zhao, J., Zhao, M., Xu, J., Ge, X., & Xu, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.838613 · Cited by 16
“The MSS is correlated with longterm risk for diabetes and CVD and is widely employed in clinical practice to identify patients with high such risks (47, 48).”
BackgroundInfluentialHu, W., Zhai, C., Sun, H., Gong, X., Cui, L., Cai, L., Zong, Q., Yu, G., Wang, F., & Zou, Y. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110260 · Cited by 14
Mazidimoradi, A., Ghavidel, F. Z., Momenimovahed, Z., Allahqoli, L., & Salehiniya, H. (2023) · Health Science Reports · doi:10.1002/hsr2.1342 · Cited by 16
Heiniger, S., Viswanathan, B., Gédéon, J., Paccaud, F. M., & Bovet, P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001358 · Cited by 15
“The risks associated with hypertension, particularly ischemic heart disease and stroke, have been well quantified [4].”
BackgroundEffects of Natural Alternative Sweeteners on Metabolic Diseases
Kim, E. (2023) · Clinical Nutrition Research · doi:10.7762/cnr.2023.12.3.229 · Cited by 16
Hao, L., Lu, A., Gao, H., Niu, J., Prabahar, K., Seraj, S. S., & Pan, Y. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.07.009 · Cited by 17
Meena, D., Huang, J., Smith, A., Yarmolinsky, J. W., Wu, S., Koskeridis, F., Ko, Y.-H., Dib, M., Antonatos, C., Vasilopoulos, Y., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf725 · Cited by 15
Impact of obesity on the evolution of outcomes in peritoneal dialysis patients
Quero, M., Comas, J., Arcos, E., Hueso, M., Sandoval, D., Montero, N., Cruzado-Boix, P., Cruzado, J. M., & Rama, I. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa055 · Cited by 13
DEEP LEARNING-BASED PREDICTION OF OBESITY LEVELS ACCORDING TO EATING HABITS AND PHYSICAL CONDITION
Kıvrak, M. (2021) · The Journal of Cognitive Systems · doi:10.52876/jcs.939875 · Cited by 13
Li, A., Li, X., Zhou, T., Ma, H., Heianza, Y., Williamson, D. A., Smith, S. R., Bray, G. A., Sacks, F. M., & Qi, L. (2022) · Diabetes · doi:10.2337/db21-0699 · Cited by 14
Spectral-domain OCT measurements in obesity: A systematic review and meta-analysis
Salehi, M. A., Karimi, A., Mohammadi, S., & Arévalo, J. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267495 · Cited by 15
“This condition serves as a risk factor for wide range of diseases, including cardiovascular diseases [4], several cancers [5], chronic kidney disease [4], diabetes mellitus [6], hypertension [6], and various musculoskeletal disorders [7].”
BackgroundThe Effect of Obesity and Body Mass Index on Hematologic Malignancies
Bilgihan, M. T., & Çiftçiler, R. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0048 · Cited by 17
Parizadeh, D., Ramezankhani, A., Momenan, A. A., Azizi, F., & Hadaegh, F. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.06.006 · Cited by 14
Veisani, Y., Khazaei, S., Jenabi, E., & Delpisheh, A. (2019) · The Journal of Tehran University Heart Center · doi:10.18502/jthc.v13i4.647 · Cited by 13
Cohort Profile: The Cohorts Consortium of Latin America and the Caribbean (CC-LAC)
Carrillo-Larco, R. M., Cesare, M. D., Hambleton, I. R., Hennis, A. J. M., Irazola, V., Stern, D., Ferreccio, C., Lotufo, P. A., Perel, P., Gregg, E. W., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa073 · Cited by 14
Self-citationMehrzad, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818839-2.00005-3 · Cited by 13
Edwards, C. H., Bjørngaard, J. H., & Kinge, J. M. (2021) · Health Economics · doi:10.1002/hec.4285 · Cited by 16
Using Body Composition Groups to Identify Children and Adolescents at Risk of Dyslipidemia
Ofenheimer, A., Breyer‐Kohansal, R., Hartl, S., Burghuber, O. C., Krach, F., Franssen, F. M. E., Wouters, E. F. �., & Breyer, M. (2021) · Children · doi:10.3390/children8111047 · Cited by 14
Lee, S., Cho, K. H., Kim, J. C., Choo, H. J., Hwang, J.-Y., Cho, H. C., & Hah, Y. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00888-5 · Cited by 12
Quehenberger, O., Armando, A. M., Cedeno, T. H., Loomba, R. S., Sanyal, A. J., & Dennis, E. A. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100647 · Cited by 13
Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications
Ebrahimi, M., Ahmadieh, H., Kanavi, M. R., Safi, S., Alipour-Parsa, S., Advani, S., Sorenson, C. M., & Sheibani, N. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1497750 · Cited by 14
Pinho‐Gomes, A., Knight, A., Critchley, J., & Pennington, M. (2020) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2020-214081 · Cited by 16
Health Effects of Metabolic Risks in the United States From 1990 to 2019
Chen, R., Safiri, S., Behzadifar, M., Kong, J. D., Zguira, M. S., Bragazzi, N. L., Zhong, W., & Zhang, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.751126 · Cited by 14
“4 mmol/L, avoiding exposing a large proportion of the population to increased risk of mortality (16).”
BackgroundChREBP-regulated lipogenesis is not required for the thermogenesis of brown adipose tissue
Wei, C., WANG, P. H., Dong, Q., Ma, X., Lu, M. H., Qi, S., Shi, J., Xie, Z., Ren, A., & Zhang, W. J. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01082-7 · Cited by 15
Body Composition of Young Women and the Consumption of Selected Nutrients
Karpińska, E., Moskwa, J., Puścion‐Jakubik, A., Naliwajko, S. K., Soroczyńska, J., Markiewicz‐Żukowska, R., & Socha, K. (2022) · Nutrients · doi:10.3390/nu15010129 · Cited by 14
Liu, Y., Wang, X., & Fang, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-62677-w · Cited by 17
Evaluation of Atrial Electromechanical Delay in Children with Obesity
Temiz, F., Güneş, H., & Güneş, H. (2019) · Medicina · doi:10.3390/medicina55060228 · Cited by 14
Trang, B. K., Pahl, M. C., Pippin, J. A., Su, C., Littleton, S. H., Sharma, P. K., Kulkarni, N. N., Ghanem, L. R., Terry, N. A., O’Brien, J. M., et al. (2025) · eLife · doi:10.7554/elife.95411.3 · Cited by 15
Wang, M., Huang, K., Jin, Y., & Zheng, Z.-J. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.47 · Cited by 13
“It was computed by taking the person-year weighted average of the fasting plasma glucose level associated with the lowest risk of mortality in the pooled analyses of prospective cohort studies (16).”
Association of obesity severity and duration with incidence of chronic kidney disease
Ghazy, F., Ebrahimi, N., Ebadinejad, A., Barzin, M., Mahdavi, M., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03757-x · Cited by 15
“Some epidemiologic studies have revealed an association between high body mass index (BMI) and a wide range of chronic diseases including cardiovascular diseases and chronic kidney disease (CKD) [5, 6].”
BackgroundChandra, M. (2024) · Children · doi:10.3390/children11111387 · Cited by 12
Zhang, X., Lin, S., Zeng, Q., Peng, L., & Yan, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1612369 · Cited by 19
Ramanujam, K., Spence, D. W., & Pandi-Perumal, S. R. (2019) · Sleep Science · doi:10.5935/1984-0063.20190061 · Cited by 13
Recent Trends of Metabolic Syndrome and Its Components in Military Recruits from Saudi Arabia
Shehri, H. A. A., Alasmari, A., Khan, H. A., Horaib, G. B., Buraidi, A. A. A., Al-Sharif, A. A., Kadasah, S., Al-Omani, S. F., Mohammed, F. S., Abbasmanthiri, R., et al. (2021) · Medicines · doi:10.3390/medicines8110065 · Cited by 11
“some risk factors that increased with age in cases of DM, HTN and BMI and they attributed this to high levels of blood sugar attained in their older ages due to inadequate involvement of individuals in physical activities [27,28].”
Cai, S., Dong, J., Cheng, B., Zhang, A., Sun, J., Li, M., Su, Y., Bao, Q., Zhu, P., & Wang, S. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02463-6 · Cited by 12
Dahl Salt-Resistant Rat Is Protected against Hypertension during Diet-Induced Obesity
Lee, S., Jang, S., Kim, J. Y., & Kim, I. (2022) · Nutrients · doi:10.3390/nu14183843 · Cited by 12
“Obesity is currently considered a pandemic and is frequently associated with metabolic syndromes such as hypertension, insulin resistance, and abnormal blood lipid levels [2,3].”
BackgroundNiu, X., Zhang, N., Li, S., Li, N., Wang, R., Zhang, Q., He, J., Sun, E., Kang, X., & Zhan, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.992947 · Cited by 12
Aging and Changes in Body Composition
van Asselt, D., & de Groot, C. P. G. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100348-0.00008-1 · Cited by 19
Tancredi, M., Rosengren, A., Svensson, A., Pivodic, A., Guðbjörnsdóttir, S., Wedel, H., & Lind, M. (2019) · Open Heart · doi:10.1136/openhrt-2018-000967 · Cited by 14
Climent, E., Pérez‐Calahorra, S., Benaiges, D., Pintó, X., Tembra, M. S., Plana, N., Sánchez-Hernández, R. M., Valdivielso, P., Ascaso, J. F., & Pedro‐Botet, J. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.09.001 · Cited by 12
Robson, E., Norris, T., Wulaningsih, W., Hamer, M., Hardy, R., & Johnson, W. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000751 · Cited by 11
Luo, S., Gill, H. S., Feltis, B., Hung, A., Nguyen, L. T., & Lenon, G. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082854 · Cited by 11
Raberin, A., Connes, P., Barthélemy, J., Robert, P., Celle, S., Hupin, D., Faës, C., Rytz, C. L., Roche, F., & Pialoux, V. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1315471 · Cited by 13
“Ageing and gender strongly modulate the risk to develop cardiovascular disease [2].”
BackgroundSingh, G., Varshney, V., Goyal, A., Ali, N., Iqbal, M., Kaur, I., Vargas-De-La-Cruz, C. B., & Behl, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22052 · Cited by 10
Self-citationCarbajal, P. B. M., Camargo, N. E. C., Espinoza-Gutiérrez, R., Calleja-Núñez, J. J., Herrera, B. M., Cerna, J., & Corona, J. A. A. (2024) · Games for Health Journal · doi:10.1089/g4h.2023.0159 · Cited by 11
Li, H., & Adair, T. (2024) · BMC Medicine · doi:10.1186/s12916-024-03752-x · Cited by 12
“Obesity is associated with increased risk of mortality from these causes [10, 12, 27, 28].”
Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes
Greaves, J., & Pula, G. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26190 · Cited by 15
Rehm, J. T., Gmel, G. E., Sierra, C., & Gual, A. (2016) · Adicciones · doi:10.20882/adicciones.726 · Cited by 12
Li, H., Sun, J. H., Li, B., Jiang, A., Tao, J., Ning, C., Li, R., & Liu, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.917801 · Cited by 11
“Epidemiological studies have indicated that a high BMI (body mass index) is closely correlated with several chronic metabolism-related diseases, including NAFLD (nonalcoholic fatty liver disease), cardiovascular disease, T2D (type 2 diabetes mellitus), and different types of cancer (1, 2).”
BackgroundWu, C., Mi, B., Luo, W., Chen, B., Ma, J., Huang, H., Zhang, Q., Wang, Y., Liu, H., Yan, B., et al. (2022) · Nutrients · doi:10.3390/nu14163373 · Cited by 13
“Obesity is an established risk factor for several kinds of chronic non-communicable diseases, such as cardiovascular diseases [5,6], type 2 diabetes [5,6], chronic kidney disease [6], and cancers [7].”
BackgroundKing, A., Graham, C., Glaister, M., Anastacio, V. D. S., Pilić, L., & Mavrommatis, Y. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad001 · Cited by 14
Sex differences in offspring of preeclamptic pregnancies
Campbell, N., Solise, D., Deer, E. M., & LaMarca, B. B. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100688 · Cited by 13
Chen, Y., Liu, J., Zhang, Q., Chen, H., Chai, L., Wang, Y., Zhang, J., Qiu, Y., Shen, N., Shi, X., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04779-x · Cited by 10
“It was calculated by taking the person-year-weighted average of the level of FPG that was associated with the lowest risk of mortality in the pooled analyses of prospective cohort studies [29].”
Alam, K., Hayat, A. H., Ullah, A., Sulaiman, S. A. S., Ahmad, W., & Ooi, G. S. (2024) · Cureus · doi:10.7759/cureus.59402 · Cited by 9
“CKD is a progressive and irreversible condition, defined as an estimated glomerular filtration rate (GFR) of 60 mL/min/1.73 m 2 and/or kidney damage (hematuria or proteinuria) present for at least three months [3].”
BackgroundInfluentialSafiri, S., Mousavi, S. E., Asghari, K. M., Nejadghaderi, S. A., Aletaha, R., Sullman, M. J. M., Singh, K., Kolahi, A., & Beyranvand, M. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-64563-x · Cited by 11
“These cohort studies showed there was an increased risk of mortality at SBP levels outside this range 13,14 .”
BackgroundHuang, L., Guo, Z., Huang, M.-J., Zeng, X., & Huang, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-71591-0 · Cited by 12
Dainelli, L., Xu, T., Li, M., Zimmermann, D., Fang, H., Wu, Y., & Detzel, P. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017136 · Cited by 10
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.